Abstract:Background Glioblastoma (GBM) is one of the deadliest cancers with no cure. While conventional MRI has been widely adopted for examining GBM clinically, accurate neuroimaging assessment of tumor histopathology for improved diagnosis, surgical planning, and treatment evaluation, remains an unmet need in the clinical management of GBMs. Methods We employ a novel Diffusion Histology Imaging (DHI) approach, combining diffusion basis spectrum imaging (DBSI) and machine learning, to detect, differentiate, and quantify areas of high cellularity, tumor necrosis, and tumor infiltration in GBM. Results Gd-enhanced T1W or hyper-intense FLAIR failed to reflect the morphological complexity underlying tumor in GBM patients. Contrary to the conventional wisdom that apparent diffusion coefficient (ADC) negatively correlates with increased tumor cellularity, we demonstrate disagreement between ADC and histologically confirmed tumor cellularity in glioblastoma specimens, whereas DBSI-derived restricted isotropic diffusion fraction positively correlated with tumor cellularity in the same specimens. By incorporating DBSI metrics as classifiers for a supervised machine learning algorithm, we accurately predicted high tumor cellularity, tumor necrosis, and tumor infiltration with 87.5%, 89.0% and 93.4% accuracy, respectively. Conclusion Our results suggest that DHI might serve as a favorable alternative to current neuroimaging techniques for guiding biopsy or surgery as well as monitoring therapeutic response in the treatment of glioblastoma. Key Points Clinical MRI lacks specificity and sensitivity in detecting morphological features in GBM. DBSI-derived morphological metrics reflect tumor cellularity, necrosis, and white matter tracts. DHI predicts and classifies key histopathological features of GBM. Importance of the Study Current clinical diagnosis, surgical resection planning, and assessment of treatment response for GBM patients relies heavily on gadolinium enhanced T1-weighted MRI, despite the enhancement is non-specific to tumor growth merely reflecting a disrupted blood-brain barrier. The complex tumor microenvironment and spatial heterogeneity make GBM very difficult to characterize using current clinical imaging modalities. In this study, we developed a novel imaging technique to characterize key histological features of GBM to accurately predict high tumor cellularity, tumor necrosis, and tumor infiltration. Current proof-of-concept approach if validated in a larger cohort of GBM patients could provide a solution resolve issues such as pseudoprogression and radiation necrosis currently plague neuroimaging modalities to assess GBM in living patients.

Radio-Pathomic Maps of Cell Density Identify Brain Tumor Invasion beyond Traditional MRI-Defined Margins

NIMG-23. COMPARISON OF A RADIO-PATHOMIC MODEL VERSUS A RADIOLOGY-ONLY TUMOR SEGMENTATION MODEL FOR THE DETECTION OF INFILTRATIVE TUMOR IN GLIOMA PATIENTS

Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement

Mapping Tumor Habitats in IDH-Wild Type Glioblastoma: Integrating MR Imaging, Pathologic, and RNA Data from Ivy Glioblastoma Atlas Project

Nimg-58. Machine Learning-Generated Whole-Brain Radio-Pathomic Tumor Probability Maps Within Contrast-Enhancement Stratify Survival In Glioblastoma Patients Undergoing Gross-Total Resection

Radiomic features of multi-parametric MRI present stable associations with analogous histological features in brain cancer patients

Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.

Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans and Bayesian Inference

Identifying Radiotherapy Target Volumes in Brain Cancer by Image Analysis.

Statistical multiscale mapping of IDH1, MGMT, and microvascular proliferation in human brain tumors from multiparametric MR and spatially-registered core biopsy

P02.11.B An hypothesis generating study of MRI-Derived Radiomics on tumor and microenvironment tissue heterogeneity to guide post-operative management of glioblastoma: toward personalized radiation treatment volume delineation

Radiotherapy planning for glioblastoma based on a tumor growth model: Improving target volume delineation

Nimg-59. Comparative Analysis Of Long-Term Glioblastoma Survivors Using Machine Learning Generated Radio-Pathomic Metrics

RADIOHEAD: Radiogenomic Analysis Incorporating Tumor Heterogeneity in Imaging Through Densities

Utilizing Radiomics of Peri-Lesional Edema in T2-FLAIR Subtraction Digital Images to Distinguish High-Grade Glial Tumors From Brain Metastasis

Diffusion Histology Imaging Detects and Classifies Glioblastoma Pathology Missed by Conventional Magnetic Resonance Imaging

Predicted disease compositions of human gliomas estimated from multiparametric MRI can predict endothelial proliferation, tumor grade, and overall survival

Nimg-55. Developing A Computational Pipeline To Forecast And Spatially Map High-Grade Glioma Response To Radiotherapy Using Biophysical Models And Data-Driven Statistical Analysis

Tumor-Associated Tractography Derived from High-Angular-Resolution Q-Space MRI May Predict Patterns of Cellular Invasion in Glioblastoma

Multiparametric magnetic resonance imaging discerns glioblastoma immune microenvironmental heterogeneity

Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation